Log in

Relevant bibliographies by topics / Epidemiologie HIV / Journal articles

To see the other types of publications on this topic, follow the link: Epidemiologie HIV.

Journal articles on the topic 'Epidemiologie HIV'

Author: Grafiati

Published: 4 June 2021

Last updated: 14 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Epidemiologie HIV.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ledergerber, Bruno, and Manuel Battegay. "Epidemiologie von HIV." Therapeutische Umschau 71, no. 8 (2014): 437–41. http://dx.doi.org/10.1024/0040-5930/a000535.

Full text

Abstract:

Im Jahr 2012 lebten weltweit ungefähr 35 Mio. Personen mit HIV, 69 % davon in Afrika südlich der Sahara. Es wurden in diesem Jahr 2.3 Mio. Personen neu mit HIV infiziert, 95 % davon in Ländern mit tiefen oder mittleren Einkommen und 1.6 Mio. Menschen starben an den Folgen von HIV und AIDS. Die sexuelle Übertragung von HIV ging in den letzten Jahren weltweit zurück, ein Resultat der vielen Therapieprogramme, die auch HIV-Tests und Prävention integrieren. Nach den neuen WHO-Behandlungsrichtlinien von 2013 erhielten 34 % der 28.6 Mio. für eine Therapie qualifizierender HIV-infizierter Menschen ei

APA, Harvard, Vancouver, ISO, and other styles

2

Fabricius, Eva-Maria. "Epidemiologie der HIV-Infektion." Klinische Monatsblätter für Augenheilkunde 202, no. 05 (1993): 460–64. http://dx.doi.org/10.1055/s-2008-1045629.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rockstroh, Jürgen Kurt. "Epidemiologie und Transmission der HIV-Infektion." Pharmazie in unserer Zeit 28, no. 2 (2007): 95–101. http://dx.doi.org/10.1002/pauz.19990280210.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brun-Vezinet, F., E. Delaporte, F. Simon, M. C. Dazza, M. Peeters, and A. G. Saimot. "Epidemiologie de l'infection HIV-2 en Afrique." Médecine et Maladies Infectieuses 18 (December 1988): 698–701. http://dx.doi.org/10.1016/s0399-077x(88)80358-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Schäfer, A., B. Schwartländer, and W. Friedmann. "Epidemiologie und Klinik der HIV-infizierten Frau." Archives of Gynecology and Obstetrics 245, no. 1-4 (1989): 173–78. http://dx.doi.org/10.1007/bf02417231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sagebiel, Daniel. "Tuberkulose – Epidemiologie, Diagnostik und Behandlung." SUCHT 53, no. 3 (2007): 177–84. http://dx.doi.org/10.1024/2007.03.08.

Full text

Abstract:

<span class="fett">Allgemeine Problemstellung:</span> Die Tuberkulose (TB) ist neben HIV/AIDS und Malaria die weltweit häufigste Infektionskrankheit. Etwa ein Drittel der Weltbevölkerung ist mit Mycobacterium tuberculosis (M. tuberculosis) infiziert, wobei 5–10 % der Betroffenen im Laufe ihres Lebens eine TB entwickeln. TB ist global weiter auf dem Vormarsch und bei HIV-Infizierten die Todesursache Nummer eins. Alle 15 Sekunden stirbt ein Mensch an TB und über 95 % der neuen TB-Fälle treten in Entwicklungsländern auf. </p><p> <span class="fett">Aktuelle Relevanz:&

APA, Harvard, Vancouver, ISO, and other styles

7

Marcus, U., and O. Hamouda. "Epidemiologie der HIV-Neuinfektion in den verschiedenen Risikogruppen." Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 43 (February 2, 2000): 3–8. http://dx.doi.org/10.1007/s001030070003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zwahlen, Gebhardt, Rickenbach, and Egger. "Die Schweizerische HIV-Kohortenstudie – Ressource für Epidemiologie und Prävention." Therapeutische Umschau 61, no. 10 (2004): 593–98. http://dx.doi.org/10.1024/0040-5930.61.10.593.

Full text

Abstract:

Die epidemiologische Situation in der Schweiz war gekennzeichnet durch einen deutlichen Rückgang in den Aidsfällen und HIV-assoziierten Todesfällen nach der Einführung der hochaktiven antiretroviralen Therapie (HAART). Die Neuinfektionen haben jedoch in den letzten Jahren wieder zugenommen und die Aidsfälle und Todesfälle nahmen nicht weiter ab. Wir diskutieren beispielhaft drei Fragenkomplexe, die für Epidemiologie und Public Health relevant und aktuell sind: (i) den Gebrauch von SHCS Daten in der Interpretation der Statistiken des Bundesamts für Gesundheit, die auf den Meldungen der Ärzte un

APA, Harvard, Vancouver, ISO, and other styles

9

Henrion, R. "Epidemiologie de la transmission materno-infantile du virus HIV." Médecine et Maladies Infectieuses 18 (December 1988): 713–18. http://dx.doi.org/10.1016/s0399-077x(88)80361-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Glück, D., K. Koerner, G. Caspari, et al. "Epidemiologie des HIV bei Blutspendern in der Bundesrepublik Deutschland." DMW - Deutsche Medizinische Wochenschrift 113, no. 36 (2008): 1383–89. http://dx.doi.org/10.1055/s-2008-1067823.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Husstedt, I. W., D. Reichelt, F. Kästner, S. Evers, and K. Hahn. "Epidemiologie und Therapie von Schmerzen und Depression bei HIV und Aids." Der Schmerz 23, no. 6 (2009): 628–39. http://dx.doi.org/10.1007/s00482-009-0846-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Glück, D., B. Kubanek, and W. Gaus. "Aktuelle Daten zur Prävalenz und Epidemiologie des HIV aus der HIV-Studie der DRK-Blutspendedienste der BRD." Transfusion Medicine and Hemotherapy 17, no. 3 (1990): 160–62. http://dx.doi.org/10.1159/000222469.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Oette, M., R. Kaiser, M. Däumer, et al. "Epidemiologie der primären Medikamentenresistenz bei chronisch HIV-Infizierten in Nordrhein-Westfalen 2001-2005." DMW - Deutsche Medizinische Wochenschrift 132, no. 18 (2007): 977–82. http://dx.doi.org/10.1055/s-2007-979365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Saleeb, P., and U. Buchwald. "Aktuelle Aspekte zur Epidemiologie, Diagnose und Therapie der Tuberkulose bei HIV-infizierten Patienten." Pneumologie 68, no. 10 (2014): 666–75. http://dx.doi.org/10.1055/s-0034-1377514.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Glück, D. "Risiko der HIV-, HCV- und HBV-Übertragung durch Blutpräparate. Aktuelle Daten 1997 und 1998 aus der Studie zur Epidemiologie von HIV und Hepatitisinfektionen bei Blutspendern in Deutschland." Transfusion Medicine and Hemotherapy 26, no. 6 (1999): 335–38. http://dx.doi.org/10.1159/000053515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Bruggmann, Philip. "Die Hepatitis-C-Epidemiologie in der Schweiz und die Rolle der Grundversorgung." Praxis 105, no. 15 (2016): 885–89. http://dx.doi.org/10.1024/1661-8157/a002424.

Full text

Abstract:

Zusammenfassung. In der Schweiz sterben jährlich mehr Personen an den Folgen von Hepatitis C als an jenen von HIV. Schätzungsweise 83 000 Menschen sind mit dem Hepatitis-C-Virus infiziert. Mehr als die Hälfte von ihnen ist nicht getestet und hat somit keine Chance, von den neuen, hochwirksamen Hepatitis-C-Medikamenten zu profitieren. Mit einer Heilung dieser systemischen Infektionskrankheit, die mit den neuen Medikamenten in über 90 % der Fälle erreicht werden kann, kann sowohl die leberbedingte als auch die extrahepatische Morbidität und Mortalität stark gesenkt werden. Mit der Vision der Eli

APA, Harvard, Vancouver, ISO, and other styles

17

Zimmerli, Werner. "Pneumonia in the patient with HIV infection." Therapeutische Umschau 58, no. 10 (2001): 620–24. http://dx.doi.org/10.1024/0040-5930.58.10.620.

Full text

Abstract:

Pneumonien gehören zu den häufigsten HIV-assoziierten Infektionen. Sie können schon früh im Verlauf der HIV-Infektion auftreten. Differentialdiagnostisch kommen vor allem bakterielle Erreger (Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae und Mycobacterium tuberculosis) und Pilze (Pneumocystis carinii, Cryptococcus neoformans, Histoplasma capsulatum) vor. Das diagnostische Vorgehen ist abhängig von der Epidemiologie (Reisen) und vom Immunstatus des Erkrankten. Bildgebende Verfahren sind immer notwendig, die mikrobiologische Untersuchung des Sputums sollte angestrebt we

APA, Harvard, Vancouver, ISO, and other styles

18

Liu, Lin, Lin Wang, Hua Zhang, et al. "Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus–Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys." Clinical Infectious Diseases 73, no. 4 (2021): 642–49. http://dx.doi.org/10.1093/cid/ciab058.

Full text

Abstract:

Abstract Background The transmission of human immunodeficiency virus (HIV) and hepatitis B virus (HBV)/hepatitis C virus (HCV) is similar in modes/routes and related risk factors. Understanding the long-term changing epidemiology of HIV, HBV, and HCV coinfection is important for evaluation of existing disease control policy and healthcare planning. We describe HBV and HCV coinfection based on the latest 2 nationwide molecular epidemiologic surveys of HIV infection in mainland China in 2007 and 2015. Methods Seroprevalence of HBV and HCV infections was determined in antiretroviral treatment (AR

APA, Harvard, Vancouver, ISO, and other styles

19

Schramm, W., and H. Krebs. "Todesursachen bei Hämophilie-Patienten in Deutschland 2006/2007." Hämostaseologie 28, S 01 (2008): S5—S11. http://dx.doi.org/10.1055/s-0037-1617110.

Full text

Abstract:

ZusammenfassungSeit 1983 (Erhebungszeitraum zurückreichend bis 1978) wird die Untersuchung zur Epidemiologie bei Patienten mit Hämophilie mit der Unterstützung einer Vielzahl von Hämophiliezentren und Behandlungseinrichtungen jeglicher Größe jährlich durchgeführt. Die aktuelle Zusammenstellung beruht auf einer breiten Datenbasis aus inzwischen fast 30 Jahren und vermag sowohl den aktuellen als auch den retrospektiven Morbiditäts- und Mortalitätsstatus gut abzubilden. Abgefragt wurden Informationen ausschließlich zu Patienten mit Hämophilie A, B und von-Willebrand- Erkrankung. Im Einzelnen wurd

APA, Harvard, Vancouver, ISO, and other styles

20

Hentrich, Marcus. "Diagnostik und Therapie der HIV-assoziierten Lymphome: Update 2021." DMW - Deutsche Medizinische Wochenschrift 146, no. 11 (2021): 724–27. http://dx.doi.org/10.1055/a-1169-0848.

Full text

Abstract:

Was ist neu? Epidemiologie und Risikofaktoren Bei Personen mit HIV ist das Risiko für ein Non-Hodgkin-Lymphom (HIV-NHL) bzw. Hodgkin-Lymphom (HIV-HL) auch unter kombinierter antiretroviraler Therapie um das 10–20- bzw. 5–15-Fache erhöht. Wichtige Risikofaktoren sind der CD4-Zell-Nadir und die kumulative HIV-Viruslast. Prognose Die Prognose wird durch den pathologischen Subtyp und den Internationalen Prognose-Index sowie durch die Zahl der CD4-Zellen bei Lymphom-Diagnose und durch molekulare Marker wie die Expression von MYC oder BCL2 bestimmt. Therapie Standardtherapie des diffus großzelligen

APA, Harvard, Vancouver, ISO, and other styles

21

Guo, Fuying, and Lingzhou Yang. "Research Progress on HIV/AIDS with Concomitant Hepatitis B Virus and/or Hepatitis C Virus Infection." Infection International 4, no. 1 (2015): 16–20. http://dx.doi.org/10.1515/ii-2017-0099.

Full text

Abstract:

Abstract Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) involve similar transmission routes, namely, blood, sexual contact, and mother-baby contact. Therefore, HIV infection is usually accompanied by HBV and HCV infections. This observation poses a great challenge to the prevention and treatment of HIV/human acquired immunodeficiency syndrome (AIDS) accompanied by HBV and HCV infection. Highly active antiretroviral therapy (HAART) has been extensively applied. Hence, liverrelated diseases have become the main causes of complication and death in HIV-inf

APA, Harvard, Vancouver, ISO, and other styles

22

Choy, Chiaw Yee, Li Wei Ang, Oon Tek Ng, Yee Sin Leo, and Chen Seong Wong. "Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006–2017." Tropical Medicine and Infectious Disease 4, no. 2 (2019): 87. http://dx.doi.org/10.3390/tropicalmed4020087.

Full text

Abstract:

Co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with human immunodeficiency virus (HIV) is associated with increased risk of hepatic complications and mortality. A retrospective study to estimate the proportion of HBV and HCV co-infections in Singapore was conducted using a clinical database. We included 3065 patients who were seen under the Clinical HIV Programme at the largest referral centre for HIV care between 2006 and 2017 and were tested for both HBV and HCV. Factors associated with HIV-HBV and HIV-HCV co-infections were determined using logistic regressions. The maj

APA, Harvard, Vancouver, ISO, and other styles

23

BUREK, V., J. HORVAT, K. BUTORAC, and R. MIKULIĆ. "Viral hepatitis B, C and HIV infection in Croatian prisons." Epidemiology and Infection 138, no. 11 (2010): 1610–20. http://dx.doi.org/10.1017/s0950268810000476.

Full text

Abstract:

SUMMARYIncarcerated persons comprise about 0·4% of the Croatian population, of whom 25–30% misuse drugs. We attempted to determine the structure of the prison population, prevalence of HBV, HCV, HIV markers, co-infections with HBV, HCV and HIV and acute HBV, HCV and HIV infection. In total, 25·9% of prisoners were positive for some markers for viral hepatitis (HBV 11·3%, HCV 8·3%, HBV/HCV 6·3%). Prevalence of HBV infection in intravenous drug users (IDUs) was 26·2% (highly promiscuous group 20·4%, individuals with psychiatric diseases and personality disorders 16·0%). HCV infection in IDUs was

APA, Harvard, Vancouver, ISO, and other styles

24

LAGA W. "Koninklijke Academie voor Geneeskunde van België. De epidemiologie en preventie van HIV in Afrika. Overzicht van het recente onderzoek." Tijdschrift voor Geneeskunde 57, no. 18 (2001): 1297. http://dx.doi.org/10.2143/tvg.57.18.5001145.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Bosh, K. A., J. R. Coyle, V. Hansen, et al. "HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities." Epidemiology and Infection 146, no. 7 (2018): 920–30. http://dx.doi.org/10.1017/s0950268818000766.

Full text

Abstract:

AbstractCoinfection with human immunodeficiency virus (HIV) and viral hepatitis is associated with high morbidity and mortality in the absence of clinical management, making identification of these cases crucial. We examined characteristics of HIV and viral hepatitis coinfections by using surveillance data from 15 US states and two cities. Each jurisdiction used an automated deterministic matching method to link surveillance data for persons with reported acute and chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, to persons reported with HIV infection. Of the 504 398 pers

APA, Harvard, Vancouver, ISO, and other styles

26

YAN, Y. X., Y. Q. GAO, X. SUN, et al. "Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients." Epidemiology and Infection 139, no. 3 (2010): 354–60. http://dx.doi.org/10.1017/s0950268810001597.

Full text

Abstract:

SUMMARYTo evaluate the prevalence of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infections in HIV-infected patients in China, an epidemiological serosurvey was conducted from May 2007 to September 2008 using a random cluster sampling design of infectious disease hospitals in seven high HIV-prevalent provinces (municipalities). Univariate analysis and logistic regression were used to study the determinants of HIV and HBV and/or HCV co-infection. The overall prevalence was 41·83% (95% CI 40·36–43·30) for anti-HCV and 12·49% (95% CI 11·50–13·48) for HBsAg, respectively. The prevalence

APA, Harvard, Vancouver, ISO, and other styles

27

Telles, Paulo Roberto, Renan Moritz R. Varnier-Almeida, and Francisco Inácio Bastos. "Infecção pelo HIV entre usuários de drogas injetáveis: análise dos fatores de risco no Município do Rio de Janeiro, Brasil." Revista Brasileira de Epidemiologia 1, no. 3 (1998): 245–55. http://dx.doi.org/10.1590/s1415-790x1998000300004.

Full text

Abstract:

O trabalho visa a determinar os fatores de risco para a infecção pelo HIV (Human Immunodeficiency Virus - vírus da aids) entre usuários de drogas injetáveis (UDI), no Município do Rio de Janeiro. Os entrevistados foram recrutados em centros de tratamento para usuários de drogas e nas "cenas de uso" ("ruas"). Foram utilizados três questionários: um destinado a colher informações mais gerais acerca dos UDI, adaptado de estudo anterior da Organização Mundial da Saúde (OMS); um segundo voltado para a pesquisa de informações suplementares sobre conhecimentos, comportamentos e atitudes em relação à

APA, Harvard, Vancouver, ISO, and other styles

28

Oliveira, Silvano Barbosa de, Edgar Merchan-Hamann, and Leila Denise Alves Ferreira Amorim. "HIV/AIDS coinfection with the hepatitis B and C viruses in Brazil." Cadernos de Saúde Pública 30, no. 2 (2014): 433–38. http://dx.doi.org/10.1590/0102-311x00010413.

Full text

Abstract:

The aim of this study is to estimate the prevalence of HIV/HBV and HIV/HCV coinfections among AIDS cases reported in Brazil, and to describe the epidemiological profile of these cases. Coinfection was identified through probabilistic record linkage of the data of all patients carrying the HIV virus recorded as AIDS patients and of those patients reported as carriers of hepatitis B or C virus in various databases from the Brazilian Ministry of Health from 1999 to 2010. In this period 370,672 AIDS cases were reported, of which 3,724 were HIV/HBV coinfections. Women are less likely to become coin

APA, Harvard, Vancouver, ISO, and other styles

29

Coppola, R. C., RE Manconi, R. Piro, M. L. Di Martino, and G. Masia. "HCV, HIV, HBV and HDV infections in intravenous drug addicts." European Journal of Epidemiology 10, no. 3 (1994): 279–83. http://dx.doi.org/10.1007/bf01719350.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Khadka, Sundar, Rupendra Shrestha, Sanjeet Pandit, Roshan Pandit, and Anup Bastola. "Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal." Case Reports in Medicine 2019 (February 11, 2019): 1–6. http://dx.doi.org/10.1155/2019/2070973.

Full text

Abstract:

Aim. Dual coinfection of HCV and HBV in HIV-1-infected population is a leading cause of morbidity and mortality. Also, they share routes of HIV transmission; however, it might be associated with an independent factor like injecting drug use for HCV and unsafe sex for HBV. This case report suggests that hepatitis virus coinfection may lead to late response of antiretroviral therapy (ART) in HIV-1 patients. Patients and Methods. A 49-year-old male patient visited for the routine follow-up investigation at the National Public Health Laboratory (NPHL), Teku, Nepal. He was an HIV-1-positive injecti

APA, Harvard, Vancouver, ISO, and other styles

31

SAMUEL, M. C., P. M. DOHERTY, M. BULTERYS, and S. A. JENISON. "Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA." Epidemiology and Infection 127, no. 3 (2001): 475–84. http://dx.doi.org/10.1017/s0950268801006197.

Full text

Abstract:

This study aimed to assess the seroprevalence and risk factors for hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV-1 infections among injecting drug users (IDU) in New Mexico. Serological and behavioural surveys were conducted in conjunction with street-based outreach, education and HIV counselling and testing. High rates of antibody positivity for HCV (82·2%) and HBV (61·1%), and a low rate for HIV (0·5%) were found. In multivariate analyses, both HBV and HCV infection were positively associated with increasing age, increasing years of injection and heroin use. Receipt of a tattoo i

APA, Harvard, Vancouver, ISO, and other styles

32

Kato-Maeda, Midori, Samuel Ponce-de-León, Jose Sifuentes-Osornio, et al. "Bloodborne Viral Infections in Patients Attending an Emergency Room in Mexico City: Estimate of Seroconversion Probability in Healthcare Workers After an Occupational Exposure." Infection Control & Hospital Epidemiology 21, no. 9 (2000): 600–602. http://dx.doi.org/10.1086/501811.

Full text

Abstract:

AbstractThe frequency of hepatitis C (HCV), hepatitis B (HBV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus (HTLV) I/II was determined in the emergency room of a teaching hospital. Of 909 patients, 19% had at least one infection; 7.8% had HCV, 6.9% HBV, 3.3% HIV, and 2.8% HTLV I/II. The probability that a healthcare worker would have an accident with an infected patient and seroconvert was 4.99 to 24.9 per 100,000 venipunctures for HBV, 5.6 to 8.4 for HCV, and 0.12-0.16 for HIV in our emergency room.

APA, Harvard, Vancouver, ISO, and other styles

33

Francisci, Daniela, Franco Baldelli, Rita Papili, Giuliano Stagni, and Sergio Pauluzzi. "Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients." European Journal of Epidemiology 11, no. 2 (1995): 123–26. http://dx.doi.org/10.1007/bf01719475.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Oliveira, Dinamene, Maria do Rosário Martins, Rita Castro, et al. "Seropositivity rate and sociodemographic factors associated to HIV, HBV, HCV and syphilis among parturients from Irene Neto Maternity of Lubango city, Angola." Sexually Transmitted Infections 96, no. 8 (2020): 587–89. http://dx.doi.org/10.1136/sextrans-2019-054249.

Full text

Abstract:

ObjectivesTo characterise infections by HIV, Treponema pallidum, hepatitis B (HBV) and C virus (HCV) in parturients admitted to Irene Neto Maternity, Lubango city, Huíla province, Angola, namely its seropositivity rate and its association with sociodemographic factors.MethodsAn observational, cross-sectional and analytical facility-based survey was conducted among 500 parturients at Irene Neto Maternity, from October 2016 to September 2017. Women in labour were screened for antibodies against HIV-1/2, T. pallidum and HCV. Antigen detection was used to diagnose HBV infections. Sociodemographic

APA, Harvard, Vancouver, ISO, and other styles

35

Slack, Mary Paulina Elizabeth. "Long Term Impact of Conjugate Vaccines on Haemophilus influenzae Meningitis: Narrative Review." Microorganisms 9, no. 5 (2021): 886. http://dx.doi.org/10.3390/microorganisms9050886.

Full text

Abstract:

H. influenzae serotype b (Hib) used to be the commonest cause of bacterial meningitis in young children. The widespread use of Hib conjugate vaccine has profoundly altered the epidemiology of H. influenzae meningitis. This short review reports on the spectrum of H. influenzae meningitis thirty years after Hib conjugate vaccine was first introduced into a National Immunization Program (NIP). Hib meningitis is now uncommon, but meningitis caused by other capsulated serotypes of H. influenzae and non-typeable strains (NTHi) should be considered. H. influenzae serotype a (Hia) has emerged as a sig

APA, Harvard, Vancouver, ISO, and other styles

36

Balde, T. A. L., S. Boumbaly, E. N. Serikova, et al. "Comparative Analysis of the Vertical Risk of Transmission of Some Blood-Borne Infections in the Republic of Guinea." Problems of Particularly Dangerous Infections, no. 1 (April 16, 2021): 87–94. http://dx.doi.org/10.21055/0370-1069-2021-1-87-94.

Full text

Abstract:

The aim of our work was to compare the HBV, HCV and HIV vertical transmission risk in the Republic of Guinea.Materials and methods. The material for the study was 305 blood plasma samples from pregnant women living in Conakry, Republic of Guinea. The samples were examined for the presence of serological (HBsAg, antibodies antiHBs IgG, anti-HBcore IgG, anti-HCV IgG, Ag/Ab-HIV) and molecular (HBV DNA, HCV RNA, HIV RNA) markers.Results and discussion. When assessing the overall prevalence of serological markers among patients, the incidence of HBV markers was 76.06 %. Antibodies to HCV were detec

APA, Harvard, Vancouver, ISO, and other styles

37

SÈNE, D., S. POL, L. PIROTH, et al. "Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study." Epidemiology and Infection 135, no. 3 (2006): 409–16. http://dx.doi.org/10.1017/s0950268806006947.

Full text

Abstract:

This prospective, multicentre study was conducted between September and October 2003 in 38 French departments of internal medicine, infectious disease and hepatogastroenterology and included 406 consecutive HBV-infected patients (positive HBsAg), half of whom were HIV-infected (53%). The aim was to outline the main characteristics of hepatitis B virus (HBV)-human immunodeficiency virus (HIV) co-infected patients in French hospitals. HBV-HIV co-infected patients (85% were receiving HAART; mean CD4 count 447±245/μl, HIV RNA load <400 copies/ml, 67% of patients), compared to HIV-negative patie

APA, Harvard, Vancouver, ISO, and other styles

38

Brindle, R. J., R. P. Eglin, A. J. Parsons, A. V. S. Hill, and J. B. Selkon. "HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey." Epidemiology and Infection 100, no. 1 (1988): 153–56. http://dx.doi.org/10.1017/s095026880006564x.

Full text

Abstract:

SUMMARYBlood samples from 13 locations in the Pacific and South-East Asia were tested for evidence of infection with human T-cell lymphotropic virus type-1 (HTLV-1), human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis delta virus (HDV). No samples were positive for antibody to HIV-1. Antibodies to HTLV-1 were found in samples from five locations, the maximum prevalence being 19%, in Vanuatu. Serological markers of HBV infection were found in all locations, the maximal prevalence being 88%, in Majuro, Micronesia. Antibodies to HDV in HBsAg positive sera were found in six

APA, Harvard, Vancouver, ISO, and other styles

39

BUSHNELL, G., N. L. STENNIS, A. M. DROBNIK, et al. "Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010." Epidemiology and Infection 143, no. 9 (2014): 1972–81. http://dx.doi.org/10.1017/s0950268814002970.

Full text

Abstract:

SUMMARYLiterature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in persons with tuberculosis (TB) disease remains limited and focused on populations outside the USA. Cross-matched New York City (NYC) TB and viral hepatitis surveillance data were used to estimate the proportion of NYC adults diagnosed with TB from 2000 to 2010 with a report of viral hepatitis infection and to describe the impact of viral hepatitis infection on TB treatment completion and death. For 9512 TB patients, HCV infection was reported in 4·2% and HBV

APA, Harvard, Vancouver, ISO, and other styles

40

Parry, S., N. Bundle, S. Ullah, et al. "Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department – uncovering the iceberg?" Epidemiology and Infection 146, no. 8 (2018): 1026–35. http://dx.doi.org/10.1017/s0950268818000870.

Full text

Abstract:

AbstractUK guidelines recommend routine HIV testing in high prevalence emergency departments (ED) and targeted testing for HBV and HCV. The ‘Going Viral’ campaign implemented opt-out blood-borne virus (BBV) testing in adults in a high prevalence ED, to assess seroprevalence, uptake, linkage to care (LTC) rates and staff time taken to achieve LTC. Diagnosis status (new/known/unknown), current engagement in care, and severity of disease was established. LTC was defined as patient informed plus ⩾1 clinic visit. A total of 6211/24 981 ED attendees were tested (uptake 25%); 257 (4.1%) were BBV posi

APA, Harvard, Vancouver, ISO, and other styles

41

GIDDING, H. F., J. AMIN, G. J. DORE, and M. G. LAW. "Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C." Epidemiology and Infection 139, no. 8 (2010): 1151–58. http://dx.doi.org/10.1017/s095026881000258x.

Full text

Abstract:

SUMMARYTo determine the extent age, sex and co-infection affect morbidity in people infected with hepatitis C virus (HCV), we performed a population-based study linking HCV notifications in New South Wales, Australia with their hospital (July 2000 to June 2006), hepatitis B virus (HBV) and HIV notification, and death records. Poisson models were used to calculate hospitalization rate ratios (RRs) for all-cause, illicit drug and liver-related admissions. Co-infection RRs were used to estimate attributable risk (AR). The 86 501 people notified with HCV contributed 422 761 person-years of observa

APA, Harvard, Vancouver, ISO, and other styles

42

Biver, Emmanuel, Alexandra Calmy, and René Rizzoli. "Bone health in HIV and hepatitis B or C infections." Therapeutic Advances in Musculoskeletal Disease 9, no. 1 (2016): 22–34. http://dx.doi.org/10.1177/1759720x16671927.

Full text

Abstract:

Chronic infections with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) add to age-dependent bone loss and may contribute to lower bone strength in the elderly. In this review, we report recent highlights on the epidemiology of bone fragility in chronic viral infections with HIV, HCV and HBV, its physiopathology and discuss the interference of antiviral therapies with bone metabolism. Chronic infections influence bone through the interactions between risk factors for bone fragility and falls (which are highly prevalent in infected patients), virus activit

APA, Harvard, Vancouver, ISO, and other styles

43

Holodniy, Mark, Gina Oda, Patricia L. Schirmer, et al. "Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment." Infection Control & Hospital Epidemiology 33, no. 7 (2012): 649–56. http://dx.doi.org/10.1086/666345.

Full text

Abstract:

Objective.To determine whether improper high-level disinfection practices during endoscopy procedures resulted in bloodborne viral infection transmission.Design.Retrospective cohort study.Setting.Four Veterans Affairs medical centers (VAMCs).Patients.Veterans who underwent colonoscopy and laryngoscopy (ear, nose, and throat [ENT]) procedures from 2003 to 2009.Methods.Patients were identified through electronic health record searches and serotested for human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV). Newly discovered case patients were linked to a potent

APA, Harvard, Vancouver, ISO, and other styles

44

Holodniy, Mark, Gina Oda, Patricia L. Schirmer, et al. "Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment." Infection Control & Hospital Epidemiology 33, no. 07 (2012): 649–56. http://dx.doi.org/10.1086/522267.

Full text

Abstract:

Objective.To determine whether improper high-level disinfection practices during endoscopy procedures resulted in bloodborne viral infection transmission.Design.Retrospective cohort study.Setting.Four Veterans Affairs medical centers (VAMCs).Patients.Veterans who underwent colonoscopy and laryngoscopy (ear, nose, and throat [ENT]) procedures from 2003 to 2009.Methods.Patients were identified through electronic health record searches and serotested for human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV). Newly discovered case patients were linked to a potent

APA, Harvard, Vancouver, ISO, and other styles

45

Kramer, Jennifer R., Thomas P. Giordano, and Hashem B. El-Serag. "Emerging epidemiologic observations in HCV/HIV coinfection." Current Hepatitis Reports 5, no. 4 (2006): 162–71. http://dx.doi.org/10.1007/s11901-006-0026-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Siddiqua, Mahmuda, A. A. Nawsher, S. Tabassum, and M. N. Islam. "Low Prevalence of Antibody to Hepatitis G Virus Among the Risk Groups and Healthy Population of Bangladesh." Bangladesh Journal of Medical Microbiology 4, no. 2 (2012): 5–8. http://dx.doi.org/10.3329/bjmm.v4i2.10822.

Full text

Abstract:

Hepatitis G virus (HGV) is a RNA virus, which was identified in 1995-1996 as a transfusion transmissible virus and is associated with acute or chronic hepatitis. The sero-prevalence of hepatitis G virus was evaluated among various risk groups and healthy controls from Bangladesh.A total of 252 subjects comprising of Intra-venous drug users (n-40), commercial sex workers (n-30), multiply transfused patients (n-62), hemodialysis patients (n-30), anti HCV positive patients (n-30), anti HIV positive patients (n-30) and healthy population (n-30) were included in this study. Antibody to hepatitis G

APA, Harvard, Vancouver, ISO, and other styles

47

Tarr, Philip, and Reno Frei. "Molekulare Früherkennung in der Infektiologie – Molekulare Diagnostik: Eine praktische Einführung für Kliniker." Therapeutische Umschau 67, no. 7 (2010): 381–86. http://dx.doi.org/10.1024/0040-5930/a000067.

Full text

Abstract:

Die Einführung von Polymerase-Kettenreaktion (PCR)-basierter DNA-Amplifikation zu Beginn der 90er-Jahre hat die Diagnostik von Infektionskrankheiten revolutioniert und fundamentale Erkenntnisse über deren Epidemiologie und Klinik erlaubt. Verglichen mit der Serologie zeichnet sich die PCR-Diagnostik durch erhöhte Sensibilität und Spezifität aus und kann eine frühere Diagnose erlauben. Sie kann, je nach klinischer Situation, im Blut, anderen klinischen Untersuchungsmaterialien oder direkt ab histopathologischen Proben durchgeführt werden. Die PCR Amplifikation von Erreger-DNA wird zur Bestätigu

APA, Harvard, Vancouver, ISO, and other styles

48

Lohiya, Ghan-Shyam, Lilia Tan-Figueroa, and Sonia Lohiya. "Bloodborne Pathogen Exposures in a Developmental Center 1993–2000." Infection Control & Hospital Epidemiology 22, no. 6 (2001): 382–85. http://dx.doi.org/10.1086/501919.

Full text

Abstract:

AbstractIn a developmental center, 257 potential bloodborne pathogen exposures (119 bites, 91 scratches, 30 sharps injuries, 17 mucosal breaks) occurred during 8 years (13,187 employee-years and 6,980 resident-years). Of the residents, 9% were hepatitis B virus (HBV) surface antigen carriers. Serological follow-up of exposed, susceptible employees and residents identified no transmission of HBV, hepatitis C virus (HCV), or human immunodeficiency (HIV) virus. This outcome has been due primarily to hepatitis B immunization and low prevalences of HCV or HIV infections among the subjects. Proper f

APA, Harvard, Vancouver, ISO, and other styles

49

Maek-a-Nantawat, Wirach, Anchalee Avihingsanon, and Pirapon June Ohata. "Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings." AIDS Research and Treatment 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/948059.

Full text

Abstract:

Hepatitis B and C infections are prevalent among HIV-infected individuals with different epidemiologic profiles, modes of transmission, natural histories, and treatments. Southeast Asian countries are classified as “highly prevalent zones,” with a rate of hepatitis B and C coinfection in people living with HIV/AIDS of approximately 3.2–11%. Majority of hepatitis B coinfection is of genotype C. Most of the patients infected with hepatitis C in Thailand have genotype 3 which is significantly related to intravenous drug use whereas, in Vietnam, it is genotype 6. The options for antiretroviral dru

APA, Harvard, Vancouver, ISO, and other styles

50

Höhne, Marina. "HCV und HGV — Klinik und Epidemiologie." Bundesgesundheitsblatt 40, no. 9 (1997): 332–35. http://dx.doi.org/10.1007/bf03044373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!